PSIP

Adverse Drug Events (ADE) due to product safety problems, and medication errors due to human factors (HF) are a major Public Health issue. They endanger the patients¿ safety and originate considerable extra hospital costs. Healthcare ICT applications should help reducing the prevalence of preventable ADE, by providing healthcare professionals and patients with relevant knowledge (guidelines, recommendations, etc.).

But their efficiency is impeded by two major drawbacks:

  • lack of reliable knowledge about ADE
  • poor ability of ICT solutions to deliver contextualised knowledge focused on the problem at hand, aggravated by a poor consideration of causative HF.

The objective of the project Patient Safety through Intelligent Procedures in Medication (PSIP) is (1) to facilitate the systematic production of epidemiological knowledge on ADE and (2) to ameliorate the entire medication cycle in a hospital environment.

The first sub-objective, SO, is to innovatively produce knowledge on ADE: to know, as exactly as possible, per hospital, their number, type, consequences and causes, including HF. Data Mining of the structured hospital data bases, and Semantic Mining of Data Collections of free-texts (letters, reports), will give a list of observed ADEs, with frequencies and probabilities, thus giving a better understanding of potential risks.

The second SO is to develop a set of innovative knowledge based on the mining results and to deliver a contextualised knowledge fitting the local risk parameters, in the form of alerts and decision support functions. This knowledge will be implemented in a PSIP-platform independently of existing ICT applications. These applications will connect to the platform to access and integrate the knowledge in their local system. The design and development cycle of the PSIP solution will be HF oriented.

Dissemination plans will be developed taking into account other uses (medical devices, primary and tertiary Healthcare).

For further information, please visit:
http://www.psip-project.eu

Project co-ordinator:
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE

Partners:

  • KITE SOLUTIONS S.N.C. DI DUNNE CATHERINE E C.
  • AALBORG UNIVERSITET
  • ORACLE FRANCE SAS
  • REGION HOVEDSTADEN
  • IBM DANMARK A/S
  • CENTRE HOSPITALIER DE DENAIN
  • VIDAL S.A.
  • IDEEA ADVERTISING SRL
  • EVALAB
  • MEDASYS SA
  • CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
  • ARISTOTLE UNIVERSITY OF THESSALONIKI
  • UMIT - PRIVATE UNIVERSITAET FUER GESUNDHEITSWISSENSCHAFTEN, MEDIZINISCHE INFORMATIK UND TECHNIK GESELLSCHAFT MBH

Timetable: from 01/2008 – to 04/2011

Total cost: € 9.946.770

EC funding: € 7.268.981

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...